Maaike Swets

91 Viral co-infections in SARS-CoV-2 4 Author Duration of study Study group Outcome reported Alosaimi (2021), Saudi Arabia NA Hospitalised patients, 14 ICU ICU admission, mortality Bhatraju (2020), USA 2 weeks in February/ March 2020 ICU patients No Castillo (2020), USA 2 weeks in March 2020 Patients with high risk at COVID-19 No Chekuri (2021), USA 1 month SARS-CoV-2 positive patients presenting at the emergency department Hospital admission, IMV, mortality Chen (2020), China 3 weeks in January 2020 SARS-CoV-2 positive patients No Ding (2020), China NA Hospitalised patients ARDS, ICU admission, mortality Drake (2020), UK February- June 2020 Hospitalised, confirmed or highly probable SARS-CoV-2 Critical care admission, IMV, hospital LOS Kawai (2021), Japan February- April 2020 Hospitalised COVID-19 patients No Kim (2020), USA March 2020 Patients tested for SARS-CoV-2 No Kim (2021), Australia March- May 2020 Hospitalised, SARS-CoV-2 positive No Nowak (2020), USA March- April 2020 Patients tested for SARS-CoV-2 No Singh (2021), USA March- August 2020 Patients tested for SARS-CoV-2 No Takahashi (2020), USA March- May 2020 Patients tested for SARS-CoV-2 No Supplementary table 2. Details of previous studies on viral co-infection. ICU = intensive care unit, IMV = Invasive mechanical ventilation, LOS = length of stay

RkJQdWJsaXNoZXIy MTk4NDMw